$1.37 EPS Expected for AbbVie Inc (ABBV)


The stock now has Weekly Volatility of 1.61% and Monthly Volatility of 1.77%. About 6,666 shares traded. L3 Technologies Inc (NYSE:LLL) has risen 18.89% since October 18, 2016 and is uptrending. It has outperformed by 10.23% the S&P500. The company reported $1.42 earnings per share for the quarter, beating the Zacks' consensus estimate of $1.40 by $0.02.

Wall Street analysts forecast that AbbVie Inc. Marco Limited Liability owns 145,601 shares or 1.74% of their U.S. portfolio.

AbbVie Inc.is a research-based biopharmaceutical company. The stock increased 4.20% or $3.87 during the last trading session, reaching $96.04.

In the transaction dated August 04, 2017, the great number of shares disposed came courtesy the Chairman of the Board and CEO; Gonzalez Richard A disposed a total of 87,899 shares at an average price of $71.02, amounting to approximately $6,242,587.

AbbVie Inc. (NYSE:ABBV) that has shown a discernible change in trend levels over the path of recent market activity. It has underperformed by 6.07% the S&P500.

Based on the latest notes released to investors, 4 analysts have issued a rating of "buy", 6 analysts "outperform", 10 analysts "hold", 0 analysts "underperform" and 0 analysts "sell". Therefore 52% are positive.

On average, analysts expect that AbbVie will report full-year sales of $7.06 billion for the current fiscal year, with estimates ranging from $27.80 billion to $28.46 billion. Piper Jaffray maintained the shares of ABBV in report on Friday, September 15 with "Buy" rating. Evercore ISI reiterated an "outperform" rating and set a $100.00 price target (up from $95.00) on shares of AbbVie in a research note on Saturday, September 30th. Vetr raised shares of AbbVie from a "hold" rating to a "buy" rating and set a $76.28 price objective on the stock in a research report on Wednesday, July 26th. On Monday, July 17 the stock rating was maintained by Deutsche Bank with "Hold". Jefferies maintained it with "Buy" rating and $9000 target in Thursday, May 25 report. In this case performance of tends to percentage rate of return for a stock for a given time frame. 71,235 shares valued at $4.67 million were sold by GONZALEZ RICHARD A on Friday, May 19. Eqis Capital Management Inc. raised its holdings in shares of AbbVie by 22.2% in the 3rd quarter. 79,800 shares valued at $5.59 million were sold by Schumacher Laura J on Wednesday, June 14. American Money Mgmt Ltd Com reported 45,157 shares stake. Founders Capital Mgmt Ltd holds 34,437 shares or 1.25% of its portfolio.

Capital One National Association decreased Facebook Inc (NASDAQ:FB) stake by 10,390 shares to 135,735 valued at $20.49 million in 2017Q2.

09/28/2017 - AbbVie Inc. had its "neutral" rating reiterated by analysts at Credit Suisse.

The company now has a P/E ratio of 23.62 and market capitalization is 153.10B. This nets out to an increase of 1.44 million shares and is a bullish sign for ABBV. Its up 0.01, from 0.99 in 2017Q1. Ffcm LLC increased its holdings in shares of AbbVie by 167.2% in the 2nd quarter.

Institutional ownership refers to the ownership stake in a company that is held by large financial organizations, pension funds or endowments. Roosevelt Invest Group Incorporated has 41,593 shares for 0.28% of their portfolio. Also, there are 0 buy, 0 sell and 0 strong sell ratings, collectively assigning a 1.86 average brokerage recommendation. The value in dollars increased from $4,000 to $21,289,000 increasing 532,125.0% for the reporting period. Invest House Lc reported 102,006 shares. America First Inv Advsrs Limited Liability has invested 0.05% in AbbVie Inc (NYSE:ABBV). Insiders own 0.23% of the company's stock. Eqis Capital Management Inc. now owns 29,983 shares of the company's stock valued at $2,664,000 after buying an additional 5,453 shares during the period. Acropolis Investment Management LLC acquired a new position in shares of AbbVie during the second quarter worth $106,000. Orca Mngmt Ltd Com holds 7,309 shares or 0.5% of its portfolio. Train Babcock stated it has 0.33% in AbbVie Inc (NYSE:ABBV). Strs Ohio has invested 0.28% in AbbVie Inc (NYSE:ABBV). Modera Wealth Mgmt Ltd invested 0.07% of its portfolio in AbbVie Inc (NYSE:ABBV). Everett Harris And Ca accumulated 435,695 shares. Prudential holds 5.47 million shares or 0.59% of its portfolio. Blb&B Advsr Limited Co holds 0.72% of its portfolio in AbbVie Inc (NYSE:ABBV) for 65,090 shares.

Analysts await J & J Snack Foods Corp (NASDAQ:JJSF) to report earnings on November, 2. They expect $1.37 earnings per share, up 13.22% or $0.16 from last year's $1.21 per share. (ABBV), Week Volatility is 2.16%, whereas Month Volatility is at 1.92%.

6 number of analysts have estimated the sales of the company for the quarter ending Oct 27, 2017, analysts estimated mean sale target of 7078.54 million while high and low sale targets are estimated at 7270 million and 6932 million respectively. Therefore 62% are positive. On Monday, July 17 the stock rating was maintained by Jefferies with "Buy". The firm has "Buy" rating given on Wednesday, October 5 by DA Davidson. Societe Generale initiated the shares of SHPG in report on Friday, December 2 with "Buy" rating.

October 13 investment analysts at Barclays made no change to the company rating of "Equal-Weight" but raised the price target from $72.00 to $90.00. The firm has "Hold" rating given on Friday, April 28 by BMO Capital Markets. It also reduced Vanguard Bd Index Fd Inc (BND) stake by 38,663 shares and now owns 113,778 shares.

Several hedge funds have recently bought and sold shares of the stock.